Assignee
GRAYBUG VISION INC
US13 patents
Top patents by PatentIndex Score
US9808531B2Nov 7, 2017
Compounds and compositions for the treatment of ocular disorders
GRAYBUG VISION INC5 citations82
US11331276B2May 17, 2022
Aggregating microparticles for medical therapy
GRAYBUG VISION INC1 citations71
US10441548B2Oct 15, 2019
Aggregating microparticles for medical therapy
GRAYBUG VISION INC1 citations71
US9956302B2May 1, 2018
Compounds and compositions for the treatment of ocular disorders
GRAYBUG VISION INC2 citations71
US11407781B2Aug 9, 2022
Equatorially modified polymer linked multimers of guanosine-3′, 5′-cyclic monophosphates
GRAYBUG VISION INC2 citations66
US11548861B2Jan 10, 2023
Drugs and compositions for the treatment of ocular disorders
GRAYBUG VISION INC0 citations61
US10159747B2Dec 25, 2018
Compounds and compositions for the treatment of ocular disorders
GRAYBUG VISION INC1 citations61
US10117950B2Nov 6, 2018
Compounds and compositions for the treatment of ocular disorders
GRAYBUG VISION INC1 citations61
US10111964B2Oct 30, 2018
Compounds and compositions for the treatment of ocular disorders
GRAYBUG VISION INC1 citations61
US10098965B2Oct 16, 2018
Compounds and compositions for the treatment of ocular disorders
GRAYBUG VISION INC1 citations61
US11564890B2Jan 31, 2023
Aggregating microparticles for medical therapy
GRAYBUG VISION INC0 citations60
US11160870B2Nov 2, 2021
Extended release microparticles and suspensions thereof for medical therapy
GRAYBUG VISION INC1 citations57
US10485876B2Nov 26, 2019
Compounds and compositions for the treatment of ocular disorders
GRAYBUG VISION INC0 citations51